In Canada and other countries, women with significant family history of breast and/or ovarian cancer are eligible for genetic testing for mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2 (BRCA1/2). This evidence concerns the gene BRCA2 and breast cancer.